Hybrid approach for end-stage heart failure treatment in a 6-month-old baby

Area of Science:

• Pediatric Cardiology
• Cardiovascular Surgery
• Medical Devices

Background:

• End-stage heart failure in infants presents significant management challenges.
• The patient, a 6-month-old female, had a history of intensive care and cardiac arrest.
• Severe left ventricular dysfunction (ejection fraction 20%), mitral regurgitation, and left atrial dilatation were noted.

Purpose of the Study:

• To evaluate the efficacy of the Giessen approach for pediatric end-stage heart failure.
• To assess the combined surgical and device-based intervention for severe heart failure.

Main Methods:

• The patient underwent surgical pulmonary artery banding.
• An 8 mm atrial flow regulator device was implanted via a hybrid per-atrial approach to unload the left atrium.
• This combined strategy aimed to improve cardiac function and reduce preload.

Main Results:

• Following the hybrid procedure, the patient showed significant improvement.
• Two months post-intervention, the infant was successfully weaned off inotropic support.
• The patient was transferred from intensive care to the general ward, indicating clinical recovery.

Conclusions:

• The Giessen approach, incorporating pulmonary artery banding and atrial flow regulator implantation, is a viable strategy for pediatric end-stage heart failure.
• This hybrid intervention effectively managed severe left ventricular dysfunction and left atrial overload.
• The successful weaning from inotropes highlights the potential of this approach for improving outcomes in critically ill pediatric cardiac patients.